SCHEMBL30890445

SCHEMBL30890445

Cc1ccc2c(n1)OC1(CN[C@H](C(N)=O)C1)C(=O)N2

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ OTUD7B Q6GQQ9 5/20 0.34
▸ BACE1 P56817 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27245141 1.00 OTUD7B (0.34) OTUD7BBACE1
SCHEMBL27244637 0.79 OTUD7B (0.33) OTUD7BBACE1
SCHEMBL27244758 0.76 OTUD7B (0.38) OTUD7B
SCHEMBL27245043 0.75 BACE1 (0.39) BACE1
Hydrochloric Acid SCHEMBL27245163 0.74 BACE1 (0.39) BACE1
SCHEMBL27244751 0.74 CCNC (0.34) BACE1
Hydrochloric Acid SCHEMBL30890534 0.72 TDP1 (0.34) —
Hydrochloric Acid SCHEMBL27244995 0.72 TDP1 (0.34) —
SCHEMBL30890668 0.72 OTUD7B (0.35) OTUD7B
SCHEMBL27245044 0.71 AKR1B1 (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback